Interleukin-33 potentiates bleomycin-induced lung injury. - Wikidata - awgldk - TriplyDB

Interleukin-33 potentiates bleomycin-induced lung injury.

Interleukin-33 potentiates bleomycin-induced lung injury.

http://www.wikidata.org/entity/Q37596499

about

The IL-1 cytokine family and its role in inflammation and fibrosis in the lung Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis Interleukin-1 Family Cytokines in Liver Diseases Innate Immunity and Biomaterials at the Nexus: Friends or Foes Update on scleroderma-associated interstitial lung disease The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice Membrane translocation of IL-33 receptor in ventilator induced lung injury Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing.Red Blood Cells Store and Release Interleukin-33 Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis.Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12 IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism.Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation.New dog and new tricks: evolving roles for IL-33 in type 2 immunity.The potential role of IL-33/ST2 signaling in fibrotic diseases.Antofine suppresses endotoxin-induced inflammation and metabolic disorder via AMP-activated protein kinase.Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.IL-33 Signaling in Lung Injury Interleukin-33 in health and disease.Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis.Cyclic stretch induced IL-33 production through HMGB1/TLR-4 signaling pathway in murine respiratory epithelial cells.Activation of heat shock response augments fibroblast growth factor-1 expression in wounded lung epithelium.The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation.Transcriptomic evidence of immune activation in macroscopically normal-appearing and scarred lung tissues in idiopathic pulmonary fibrosis.Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation.Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases.The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin.The Impact of Invariant NKT Cells in Sterile Inflammation: The Possible Contribution of the Alarmin/Cytokine IL-33 IL-33/ST2 Axis in Organ Fibrosis

P2860

Q26752849-DD3B4006-8CEC-4BBD-8943-7B2257EAA5B1 Q26774652-38451F67-7A09-4FC5-A4A3-6E6158BF1336 Q26778553-50064544-2CA2-4F8F-9AD2-94808F170FAC Q26801604-2E622A67-C7B3-48E7-B64F-1F5D5F01784D Q27016132-2466CD05-373E-4F42-BA77-9F2B4B283D71 Q28070412-957BC3BD-914D-401F-9835-48DF446A55E9 Q34647885-873BA89C-8252-4066-B935-7E1A493D1E8B Q35224970-01D5C585-F3DC-4A80-A9AD-B196F43597D2 Q36053010-10034C1A-173B-4D4F-BB8C-9330C1C91A2D Q36281721-77BD08F5-8D0C-44F3-A620-ADED691EFA14 Q36514695-3D2F5E3E-1A67-4445-B040-5B0FB9510ACC Q36618369-712F31E0-AEE3-4052-BD09-C89E551F447F Q36976599-BBA1B020-EB6C-46AF-B0DC-DFE8BA76B925 Q37681533-3D078021-B74C-46CF-AF0C-2785FAF63A8D Q37727601-5174F825-FE9B-4D15-9FEA-AE6EA2D4C60F Q38283789-8D5B0FCD-406A-4A18-A280-2B94A9B55184 Q38388349-3CB24F71-6A9F-49D7-A57B-309A2C39B593 Q38424483-6BA85163-EA96-402C-A596-102D9D1780E5 Q38626002-BF06387D-EAF6-425A-B0BA-9513356CB4B0 Q38742473-741E73E3-D33C-4BAC-83B1-07B4B20A3B8C Q38753216-C4DC3373-7056-46B0-B136-CDA9CE5330E6 Q38849140-FDD21FD4-A66F-48E2-B73A-2E1D86CC2D8A Q38859663-9F6FE25F-26AA-4BDD-A024-E725DCB5112D Q38930643-76F76A5F-1471-4EFE-83D6-3719C6C1F3ED Q38957840-71AA7E6C-E1E6-430F-8D87-18FBE1838D24 Q40687007-E542D376-0AAD-4F09-92F7-FA70E899B214 Q41227461-76FD2342-D166-4720-810D-AF7CB7F95629 Q42784197-5FCFFA1C-C573-4B36-A9A0-BA531D498DD2 Q47414882-01E78681-1829-466D-B022-1B5F8EBCAC4A Q47656873-69A8D289-D327-4D28-B4D5-A969CE954837 Q47719552-E93CC7CE-7A25-4AD0-8210-96AD93EFA9ED Q47736517-78176985-B45B-49C0-9291-E8A4B5217709 Q48168794-3E324AA5-7901-4E46-B6FB-CB71EB5F7520 Q53402699-92043EC0-B356-42F7-97FB-5C699A215C4A Q55475220-7F76E323-5611-4E80-91A8-B494914F5961 Q58122075-343175AD-EB9D-42D0-A098-67C809D4F1B1 Q58566658-09C4FB8E-F3A7-4B6C-8DF9-B415BDAF7379

P2860

Interleukin-33 potentiates bleomycin-induced lung injury.

http://www.wikidata.org/entity/Q37596499

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interleukin-33 potentiates bleomycin-induced lung injury.

@en

Interleukin-33 potentiates bleomycin-induced lung injury.

@nl

type

label

Interleukin-33 potentiates bleomycin-induced lung injury.

@en

Interleukin-33 potentiates bleomycin-induced lung injury.

@nl

prefLabel

Interleukin-33 potentiates bleomycin-induced lung injury.

@en

Interleukin-33 potentiates bleomycin-induced lung injury.

@nl

P1433

Q37596499-4130B1C6-6377-4B75-BCA4-197C7BC9F177

P1476

Q37596499-D7674960-99A5-4493-9883-A312DCDECE50

P2093

Q37596499-04C53F9F-9DE2-4713-A710-3C532C85A284

Q37596499-27C5E98C-0ED5-4DFC-B8EB-0C99FC30527F

Q37596499-35234648-60E7-487C-B0DB-23CDAA98E6B7

Q37596499-3D8D21BC-7D5C-40CD-9F82-1C5972A71AED

Q37596499-9201B67A-2B48-40AD-975C-BB2E18CCD795

Q37596499-9F190F74-5BCE-4A48-AC9D-FF1331809A21

Q37596499-E8247070-207F-4163-B9A5-3E719F71AD8D

Q37596499-F7C7EF0B-99B7-47A6-955C-BF7698159A2A

Q37596499-FBEBFBF4-1DFB-433D-A74F-3605E3660401

P2860

Q37596499-0029CA1C-37DC-4B97-B294-2EEEE5D25939

Q37596499-053F3536-175D-4A7A-812D-05B3DCAB8216

Q37596499-08916CC5-71A0-47CF-A326-FD716713EFD5

Q37596499-0CD9E9AF-5333-48B5-919D-D1D17DE1B54A

Q37596499-1836D8B1-75A9-416D-B536-704CE16B4F00

Q37596499-188B1D81-3160-468C-A4C4-5577AF5109E5

Q37596499-18CDD79C-56E4-4820-9AF4-6DD6DF4C1E22

Q37596499-1C9FABAB-C66A-4B6A-8905-D9B899A55217

Q37596499-2B87322A-2A6B-4ECD-8E68-5FAEE7A7F58E

Q37596499-2D2C156E-A1B9-47BD-A410-4CD4EB95BDBE

P304

Q37596499-2E107827-2B1F-4057-8E54-8A20009B6555

P31

Q37596499-19E6537A-C6BD-40FB-8849-2F0F8ECC933F

P356

Q37596499-1227EC3D-522D-4F63-948B-54B723F76519

P433

Q37596499-E929ED59-C63A-4622-BC1E-EC75AA29FEA3

P478

Q37596499-17B37BD2-0D64-4B62-84DC-48FDC15AB995

P577

Q37596499-75CA4261-42A2-4778-8AD8-FC3276B81AF7

P698

Q37596499-F9F442FB-4BBE-4B4B-9CD2-6C38B4AF6CDE

P921

Q37596499-4364f56a-181b-4aab-a78d-58dcf6c46e3e

P932

Q37596499-DCA5B745-02AF-4F6E-915C-3CA453E91C32

P356

RCMB.2013-0093OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Interleukin-33 potentiates bleomycin-induced lung injury.

@en

P2093

Allen P Burke

http://www.w3.org/2001/XMLSchema#string

Ashish Nagarsekar

http://www.w3.org/2001/XMLSchema#string

Irina G Luzina

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Hasday

http://www.w3.org/2001/XMLSchema#string

Nevins W Todd

http://www.w3.org/2001/XMLSchema#string

Pavel Kopach

http://www.w3.org/2001/XMLSchema#string

Phillip H Kang

http://www.w3.org/2001/XMLSchema#string

Sergei P Atamas

http://www.w3.org/2001/XMLSchema#string

Virginia Lockatell

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Transcription factor RORα is critical for nuocyte development

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

Interleukin-33 and the function of innate lymphoid cells

Integrin-mediated activation of latent transforming growth factor beta

Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis

Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model

Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia.

P304

999-1008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2013-0093OC

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23837438

http://www.w3.org/2001/XMLSchema#string

P921

P932

3931117

http://www.w3.org/2001/XMLSchema#string